Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
  • Our Work
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Policy & Advocacy
    • Health Equity
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Participate in Trial
    • Volunteer
    • Events
    • Resources
  • Store
  • Donate
0

Medical Marijuana for PTSD in Veterans – Study Timeline

MAPS Awarded $12.9 Million Grant from Michigan to Expand Cannabis Research for Veterans with PTSD

MAPS) has been awarded a $12,979,050 grant from Michigan’s $20 million competitive 2021 Veteran Marijuana Research Grant Program. The program, which is funded by adult-use marijuana retail taxes, is …
August 10, 2021

Data Unblinded for First Clinical Trial of Marijuana for PTSD in Veterans

On February 26, 2019, MAPS Public Benefit Corporation (MAPS PBC) staff and researchers gathered for a publication meeting and data unblinding for the MAPS-sponsored clinical trial of smoked marijuana (cannabis) …
February 26, 2019

Researchers Complete First Clinical Trial of Marijuana for PTSD in Veterans

On February 8, 2019, MAPS-sponsored researchers officially completed the first-ever clinical trial of smoked marijuana (cannabis) as a treatment for PTSD symptoms, with all 76 veterans enrolled and treated. …
February 8, 2019

All Participants Completed Treatment in Smoked Marijuana Trial for Chronic PTSD in Veterans

As of November 1, 2018, all participants completed treatment in the first-ever clinical trial of smoked marijuana (cannabis) for treatment of symptoms of posttraumatic stress disorder (PTSD) in U.S. veterans. …
November 2, 2018

76th and Final Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

As of October 8, 2018, the 76th and final participant enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for treatment of symptoms of posttraumatic stress …
October 8, 2018

75th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

As of September 18, 2018, 75 of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for treatment of symptoms of posttraumatic stress disorder …
September 18, 2018

71st Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

As of Thursday, August 9, 2018, 71 of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for treatment of symptoms of posttraumatic stress …
August 9, 2018

69th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

As of Wednesday, July 18, 2018, 69 of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in U.S. veterans. …
July 18, 2018

64th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

As of Wednesday, June 13, 2018, the 64th of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in …
June 14, 2018

60th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

On May 16, 2018, the 60th of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in U.S. veterans. …
May 17, 2018

55th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

On April 6, 2018, the 55th of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in U.S. veterans. …
April 7, 2018

50th Participant Enrolls in Smoked Marijuana Trial for Chronic PTSD in Veterans

On March 28, 2018, the 50th of 76 participants enrolled and received study drug in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in U.S. veterans. …
March 29, 2018

Posts navigation

Page 1 … Page 6 Older Posts
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
  • Our Work
    • MAPS Public Benefit Corp
    • MDMA Therapy Training
    • Zendo Project
    • Health Equity
    • Policy & Advocacy
  • Our Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up



  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit

Login

© 1986 - 2022 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117. All Rights Reserved. Proudly powered by WordPress. Hosted by Pressable